Key terms
About SLGL
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SLGL news
No recent news articles are available for SLGL
No recent press releases are available for SLGL
SLGL Financials
Key terms
Ad Feedback
SLGL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SLGL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range